BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizdrak M, Tičinović Kurir T, Božić J. The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives. Biomedicines 2021;9:174. [PMID: 33578890 DOI: 10.3390/biomedicines9020174] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu K, Yuan X, Zhao L, Wang B, Zhang Y. Comprehensive pan-cancer analysis and the regulatory mechanism of AURKA, a gene associated with prognosis of ferroptosis of adrenal cortical carcinoma in the tumor micro-environment. Front Genet 2022;13:996180. [PMID: 36685952 DOI: 10.3389/fgene.2022.996180] [Reference Citation Analysis]
2 Gambella A, Volante M, Papotti M. Histopathologic Features of Adrenal Cortical Carcinoma. Adv Anat Pathol 2023;30:34-46. [PMID: 36084635 DOI: 10.1097/PAP.0000000000000363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Turai PI, Nyirő G, Borka K, Micsik T, Likó I, Patócs A, Igaz P. Exploratory Circular RNA Profiling in Adrenocortical Tumors. Cancers (Basel) 2022;14:4313. [PMID: 36077848 DOI: 10.3390/cancers14174313] [Reference Citation Analysis]
4 Temnyy AS, Kazantsev AP. Influence of molecular genetic factors on the prognosis of localized and locally advanced adrenocortical cancer in children. Ross ž det gematol onkol 2022;9:39-45. [DOI: 10.21682/2311-1267-2022-9-2-39-45] [Reference Citation Analysis]
5 Leng D, Zheng L, Wen Y, Zhang Y, Wu L, Wang J, Wang M, Zhang Z, He S, Bo X. A benchmark study of deep learning-based multi-omics data fusion methods for cancer. Genome Biol 2022;23:171. [PMID: 35945544 DOI: 10.1186/s13059-022-02739-2] [Reference Citation Analysis]
6 Detomas M, Pivonello C, Pellegrini B, Landwehr L, Sbiera S, Pivonello R, Ronchi CL, Colao A, Altieri B, De Martino MC. MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma. Cells 2022;11:2234. [DOI: 10.3390/cells11142234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yu S, Ma J. Spindle and Kinetochore-Associated Complex is Associated With Poor Prognosis in Adrenocortical Carcinoma. J Surg Res 2022;277:50-9. [PMID: 35460921 DOI: 10.1016/j.jss.2022.03.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cheng Y, Kou W, Zhu D, Yu X, Zhu Y. Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers. Front Endocrinol 2022;12:811293. [DOI: 10.3389/fendo.2021.811293] [Reference Citation Analysis]
9 Porubayeva E, Pachuashvili N, Urusova L. Multifactorial assessment of prognostic features of adrenocortical cancer. Arkh patol 2022;84:20. [DOI: 10.17116/patol20228405120] [Reference Citation Analysis]
10 Mytareli C, Delivanis DA, Athanassouli F, Kalotychou V, Mantzourani M, Kassi E, Angelousi A. The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review. Biomedicines 2021;9:1501. [PMID: 34829730 DOI: 10.3390/biomedicines9111501] [Reference Citation Analysis]
11 Pieckowski M, Kowalski P, Olędzka I, Miękus-Purwin N, Plenis A, Roszkowska A, Bączek T. Simultaneous determination of mitotane, its metabolite, and five steroid hormones in urine samples by capillary electrophoresis using β-CD2 SDS1 complexes as hydrophobic compounds solubilizers. Electrophoresis 2021. [PMID: 34633693 DOI: 10.1002/elps.202100250] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Uchihara M, Tanioka M, Kojima Y, Nishikawa T, Sudo K, Shimoi T, Noguchi E, Maeshima AM, Yonemori K. Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience. Int J Clin Oncol 2021;26:2275-81. [PMID: 34468885 DOI: 10.1007/s10147-021-02021-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jang HN, Moon SJ, Jung KC, Kim SW, Kim H, Han D, Kim JH. Mass Spectrometry-Based Proteomic Discovery of Prognostic Biomarkers in Adrenal Cortical Carcinoma. Cancers (Basel) 2021;13:3890. [PMID: 34359790 DOI: 10.3390/cancers13153890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Arıkan MG, Öz GA, İşkan NG, Süt N, Yüksel İ, Arda E. Can Hematological Parameters Play a Role in the Differential Diagnosis of Adrenal Tumors? Uro 2021;1:39-44. [DOI: 10.3390/uro1020006] [Reference Citation Analysis]